Skip to main content

Dr. Bindra is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Bindra's full profile

Already have an account?

Education & Training

  • Memorial Sloan-Kettering Cancer Center
    Memorial Sloan-Kettering Cancer CenterResidency, Radiation Oncology, 2008 - 2012
  • Yale University School of Medicine
    Yale University School of MedicineClass of 2007

Certifications & Licensure

  • NJ State Medical License
    NJ State Medical License 2014 - 2019
  • CT State Medical License
    CT State Medical License 2012 - 2022
  • NY State Medical License
    NY State Medical License 2008 - 2012
  • American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Krebs-Cycle-Deficient Hereditary Cancer Syndromes Are Defined by Defects in Homologous-Recombination DNA Repair  
    Brian Shuch, Ranjit S Bindra, Christopher D Corso, Peter M Glazer, Nature

Abstracts/Posters

  • PARP Inhibitors Are Effective in IDH1/2 Mutant MDS and AML Resistant to Targeted IDH Inhibitors
    Ranjit Bindra, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • The PRIME Trial: PARP Inhibition in IDH Mutant Effectiveness Trial. a Phase II Study of Olaparib in Isocitrate Dehydrogenase (IDH) Mutant Relapsed/Refractory Acute Mye...
    Ranjit Bindra, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

  • Unlocking PARP inhibitor efficacy for HRD-negative cancers using the alphalex tumor targeting platform inhibitor efficacy for HRD-negative cancers using the alphalex t... 
    2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

  • Scientists Identify Deadly Brain Cancer in Kids - Siasat Daily
    Scientists Identify Deadly Brain Cancer in Kids - Siasat DailyAugust 22nd, 2020
  • International Team Discovers Unique Pathway for Treating Deadly Children's Brain Cancer
    International Team Discovers Unique Pathway for Treating Deadly Children's Brain CancerAugust 24th, 2019
  • Journal Honors Deborah Blythe Doroshow, MD, PhD, as Recipient of the 2019 Journal of Clinical Oncology Young Investigator Award
    Journal Honors Deborah Blythe Doroshow, MD, PhD, as Recipient of the 2019 Journal of Clinical Oncology Young Investigator AwardAugust 1st, 2019
  • Join now to see all

Hospital Affiliations